Abstract submission deadline 15 June 2019
TOP STORIES & SCIENTIFIC HIGHLIGHTS
GLOBAL ATLAS OF SKIN ALLERGY
The brand new Global Atlas of Skin Allergy is now available online in early release!!
Access it here.
The “Global Atlas of Skin Allergy” contains 113 chapters writtn by 118 authors with 92 clinical pictures, 105 illustratins and 70 tables. It covers the basics of skin immunology and mechanisms in the skin, epidemiology, nomenclature, histopathology, skin allergy tests as key elements for allergy diagnosis, the clinical pictures of cutaneous allergic reactins and diffrentil diagnoses, guidance on recognitin and management, a comprehensive global assessment of burden as well as
strategies for the management allergic skin diseases.
Access it here.
ISMA 2019 - Registration and abstract submission open
ISMA is the place to discuss the newest developments in the field of molecular allergology and the impact they will have on allergy diagnosis and therapy.
Don't miss the early bird registration. Register now here. For other information visit the ISMA website.
Don't miss the early bird registration. Register now here. For other information visit the ISMA website.
Don't miss the 10th anniversary of PAAM!
This year EAACI will celebrate the 10th anniversary of the EAACI Pediatric Allergy & Asthma Meeting (PAAM 2019), taking place from 17 – 19 October at the Fortezza da Basso of Florence, Italy.
EAACI guidelines on AIT: Allergic Asthma
EAACI has developed a clinical practice guideline providing evidence-based recommendations for the use of house dust mite (HDM) AIT as add-on treatment for HDM-driven allergic asthma.
This Guideline has been prepared by the Taskforce on AIT for Allergic Asthma and is part of the EAACI Guidelines on Allergen Immunotherapy. Recommendations were formulated by a multi-disciplinary working group aiming to provide indications and contraindications to HDM AIT as add-on treatment for HDM-driven allergic asthma and to identify gaps in knowledge and/or implementation, unmet needs and future perspectives.
The new EAACI Guidelines on Allergen Immunotherapy: house dust mite-driven allergic asthma are now out!
This Guideline has been prepared by the Taskforce on AIT for Allergic Asthma and is part of the EAACI Guidelines on Allergen Immunotherapy. Recommendations were formulated by a multi-disciplinary working group aiming to provide indications and contraindications to HDM AIT as add-on treatment for HDM-driven allergic asthma and to identify gaps in knowledge and/or implementation, unmet needs and future perspectives.
The new EAACI Guidelines on Allergen Immunotherapy: house dust mite-driven allergic asthma are now out!
EAACI WHITE PAPER
Committed to inscreasing allergy awareness and driving policy changes for improved patient care. The EAACI White Paper tackles research-innovation-quality of care nexus for allergic diseases and asthma.
Download here the EAACI White Paper
Download here the EAACI White Paper